Most medicine shortages are not sudden events. They are the foreseeable outcome of sustained price compression, narrowing supplier participation, and shifting market behaviour that form long before availability is affected.
Early strain rarely arrives as an alert. It appears as rational, explainable changes that are easy to dismiss in isolation.
When those changes converge, volatility becomes structure, and by the time disruption is declared, the room to act has already narrowed.
A shortage is not the start.
It’s the end of a process that was visible much earlier.
By the time a medicine is labelled “in shortage,” supplier depth has narrowed, prices have compressed, and behaviour has already shifted.
The first signal is rarely availability.
It is economics.
Long before a product disappears from the shelf, participation thins. Margins erode. Availability becomes uneven.
Early strain doesn’t look dramatic.
It looks rational.
A supplier chooses not to quote.
A lead time stretches “temporarily.”
A price holds below sustainability.
Each decision makes sense in isolation.
That’s the camouflage.
Nothing looks broken.
So nothing feels urgent.
That’s why it’s missed.
One indicator is noise. Convergence isn’t.
Structure forms at the intersection – not the extremes.
Price alone doesn’t create fragility.
Availability alone doesn’t define strain.
A supplier exit alone doesn’t define strain.
But when price compression, supplier exits, and uneven availability begin to align, the market doesn’t fluctuate.
It tightens.
Most teams monitor indicators.
Few monitor convergence.
By the time convergence becomes visible as disruption, the outcome is already forming.
This isn’t incompetence.
It’s incentive structure.
Most organisations reward solving visible problems - not anticipating invisible ones.
Acting early looks expensive. Acting late looks necessary.
Data sits fragmented across commercial, supply, and regulatory functions.
No one owns “too early.”
So we wait for the alert.
When the alert arrives, the structure is already set.
Markets don’t fail suddenly.
They weaken structurally - long before anyone calls it failure.
The hidden variable is time.
Early visibility doesn’t make you faster. It makes you earlier.
It gives you time.
Time to align.
Time to communicate.
Time to choose.
Once disruption is declared, time is gone.
And with it, most options.
This isn’t volatility.
Calling it volatility is comforting.
Volatility suggests randomness.
Years of price compression pushing out suppliers is not random.
Reduced participation concentrating risk is not random.
Structural fragility is not random.
Shortages are rarely surprises.
They are structural outcomes.
That’s not noise.
It’s design.
Early visibility does not change the economics of the market.
It changes how exposed you are when those economics play out.
The difference between reacting and leading
is when you see the structure forming.